CUE

0.5552

1.05% -0.0059

Pre-mercato: .57 0.0148 +2.67%

Cue Biopharma Inc (CUE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.5611

Aprire:

$0.5611

Volume 24 ore:

183.55K

Relative Volume:

0.69

Capitalizzazione di mercato:

$43.72M

Reddito:

$9.53M

Utile/perdita netta:

$-44.61M

Rapporto P/E:

-0.6101

EPS:

-0.91

Flusso di cassa netto:

$-38.32M

1 W Prestazione:

-11.28%

1M Prestazione:

-23.02%

6M Prestazione:

-10.45%

1 anno Prestazione:

-46.10%

Intervallo 1D:

$0.555

$0.5898

Intervallo di 1 settimana:

$0.5537

$0.6528

Portata 52W:

$0.54

$1.75

Cue Biopharma Inc Stock (CUE) Company Profile

Nome

Cue Biopharma Inc

Settore

Healthcare (1131)

Industria

Biotechnology (632)

Telefono

617-949-2680

Indirizzo

40 GUEST STREET, BOSTON, MA

Dipendente

Cinguettio

@cuebiopharma

Prossima data di guadagno

2025-03-31

Ultimi documenti SEC

CUE's Discussions on Twitter

Confronta CUE con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CUE Cue Biopharma Inc	0.5552	44.18M	9.53M	-44.61M	-38.32M	-0.91
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-03-13	Iniziato	Jefferies	Buy
2023-06-26	Ripresa	Oppenheimer	Outperform
2022-11-21	Iniziato	Piper Sandler	Overweight
2022-01-13	Iniziato	H.C. Wainwright	Buy
2022-01-03	Iniziato	Craig Hallum	Buy
2020-11-24	Iniziato	Berenberg	Buy
2020-04-09	Iniziato	Stifel	Buy
2020-01-28	Iniziato	BTIG Research	Buy
2020-01-22	Iniziato	JMP Securities	Mkt Outperform

Mostra tutto

Cue Biopharma Inc Borsa (CUE) Ultime notizie

Dec 04, 2025

Will Cue Biopharma Inc. stock continue upward momentum2025 Price Momentum & Fast Gain Stock Trading Tips - Newser

Dec 04, 2025

Is Cue Biopharma Inc. stock a safe investment in uncertain marketsDip Buying & Stepwise Trade Signal Implementation - Newser

Dec 04, 2025

How Cue Biopharma Inc. stock reacts to inflationary pressuresTrade Signal Summary & Real-Time Volume Triggers - Newser

Dec 04, 2025

Is Cue Biopharma Inc. (1UC) stock dividend growth reliableSwing Trade & Community Consensus Picks - Newser

Dec 04, 2025

Dec 03, 2025

Is Cue Biopharma Inc. (1UC) stock testing key supportStop Loss & Long-Term Safe Investment Ideas - Newser

Dec 03, 2025

Dec 02, 2025

What Wall Street predicts for Cue Biopharma Inc. stock price2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser

Dec 02, 2025

Will Cue Biopharma Inc. (1UC) stock benefit from infrastructure billQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025

How Cue Biopharma Inc. (1UC) stock moves in volatile trading sessionsOil Prices & High Conviction Buy Zone Alerts - Newser

Dec 02, 2025

Nov 30, 2025

Can Cue Biopharma Inc. stock rebound after recent weakness2025 Volume Leaders & Technical Buy Zone Confirmation - BỘ NỘI VỤ

Nov 30, 2025

Nov 27, 2025

Is Cue Biopharma Inc (CUE) positioned for future growth? - Setenews

Nov 27, 2025

Nov 26, 2025

Will Cue Biopharma Inc. stock benefit from AI adoptionMarket Risk Summary & Community Supported Trade Ideas - moha.gov.vn

Nov 26, 2025

Nov 25, 2025

[Form 4] Cue Biopharma, Inc. Insider Trading Activity - Stock Titan

Nov 25, 2025

Nov 24, 2025

Cue Biopharma Releases Updated Corporate Presentation - TipRanks

Nov 24, 2025

[8-K] Cue Biopharma, Inc. Reports Material Event | CUE SEC FilingForm 8-K - Stock Titan

Nov 24, 2025

Nov 23, 2025